Kimberly-Clark, US4943681035

Kimberly-Clark stock holds steady as revenue and margin targets stay in focus

Published on 07/23/2026 at 13:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Kimberly-Clark stock remains centered on earnings power after fiscal 2025 net sales reached $20.9 billion and adjusted EPS came in at $7.50.

Flatlay mit Aktienzertifikat, ISIN-Kärtchen und weißen Papierprodukten auf Marmortisch
Kimberly-Clark (US4943681035) Flatlay zeigt Aktienzertifikat, ISIN-Karte, Papierrollen und Füllfederhalter auf weißem Marmortisch, Illustration mit AI erstellt.

Kimberly-Clark (US4943681035) remains a cash-flow and margin story for investors, with fiscal 2025 net sales of $20.9 billion and adjusted earnings per share of $7.50. The company also reported a full-year organic sales increase of 3% and adjusted operating profit growth of 4% in 2025, according to its latest investor materials on Kimberly-Clark Investor Relations.

Net sales at $20.9 billion

For Kimberly-Clark stock, the key number is not only the $20.9 billion in fiscal 2025 sales, but also the 3% organic growth rate behind it. That combination shows the group can still expand the top line while defending profitability in a consumer staples market where volume and pricing both matter.

Adjusted EPS of $7.50 for fiscal 2025 gives the same message from the bottom line. The 4% increase in adjusted operating profit in 2025 adds a second layer of support, because it suggests the company did more than simply pass through higher costs.

Margin and earnings matter

The margin picture is what investors tend to watch next. In fiscal 2025, Kimberly-Clark said adjusted operating profit increased 4%, which means earnings quality matters as much as the sales base when the stock is priced on stable consumer demand.

The comparison is straightforward: 3% organic sales growth and 4% adjusted operating profit growth in the same fiscal year point to modest operating leverage. That matters because a consumer goods group can post higher sales without creating much shareholder value if margins do not follow.

Read deeper

Kimberly-Clark shares and full-year metrics

The latest company metrics show where revenue, profit and organic growth landed in fiscal 2025.

Consumer staples lens

Kimberly-Clark stock is best read through the lens of household essentials, where branded products such as Huggies and Kleenex can cushion demand compared with more cyclical sectors. The 2025 figures suggest that the company is still translating that portfolio into steady revenue and earnings growth.

For the market, the important point is that the latest reported numbers already carry a dated reference point: fiscal 2025 net sales of $20.9 billion, adjusted EPS of $7.50, and adjusted operating profit growth of 4%. Those are the anchors that matter when no fresh price catalyst is needed to understand the name.

Huggies and Kleenex

Huggies remains one of Kimberly-Clark's largest consumer lines, while Kleenex continues to carry global brand value across tissues and household paper products. Those categories matter because they help explain why the company can keep producing revenue and profit even when consumer spending patterns slow.

The product mix also helps frame the 2025 operating performance. A 3% organic sales increase and 4% adjusted operating profit growth indicate that the portfolio still has pricing and efficiency support behind it.

Price context today

As of 23 July 2026, the stock section of the story is best anchored by the latest reported operating figures rather than a fresh quoted price. Kimberly-Clark's fiscal 2025 net sales of $20.9 billion, adjusted EPS of $7.50, and adjusted operating profit growth of 4% remain the clearest evidence base for the current share narrative.

Kimberly-Clark stock facts

  • Company: Kimberly-Clark Corporation
  • ISIN: US4943681035
  • Ticker: NYSE: KMB
  • Trading venue: NYSE
  • Sector / Industry: Consumer Staples / Household Products
  • Index membership: S&P 500
  • Next earnings date: 30 July 2026

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US4943681035 | KIMBERLY-CLARK | boerse | 69851270 | bgmi